Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2020 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the Third Quarter 2020

GAITHERSBURG, Md., Oct. 29, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its third...
October 28, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

Project to look at rapid molecular diagnostics for travel related and enteric diseases in small animalsVeterinary applications to be developed on Unyvero A30 RQ platformCuretis to collaborate with...
October 15, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020

OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in...
October 13, 2020 17:00 ET | Source: OpGen, Inc.

OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel

OpGen’s Acuitas AMR Gene Panel allows testing for a very comprehensive panel of more than 40 diagnostic targets (pathogens and genetic AMR markers) in pure bacterial coloniesOnce FDA cleared, OpGen...
October 05, 2020 08:19 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud

Ares Genetics wins Austrian Digitization Award for Digital Products and Solutions ares-genetics.cloud for AI-powered Antibiotic Resistance Prediction awarded by Federal Ministry for Digital and...
September 30, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators

Project: AI based Assay Development for carbapenem-resistance based on porin loss and efflux pump overexpression in Gram-negative bacteriaProject is part of the Research Campus InfectoGnostics and...
September 28, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Successful Completion of Study Collaboration with Karolinska Institutet on Bacterial Co-Infections in COVID-19 Pneumonia Patients and Presents Data on Unyvero HPN Panel at ECCVID 2020

Rapid and accurate detection is essential to assess bacterial pneumonia co-infection in COVID-19 critically ill patients Unyvero HPN panel demonstrated high negative predictive value (99.8%...
September 18, 2020 16:30 ET | Source: OpGen, Inc.

OpGen, Inc. Announces Notice of Annual Meeting Venue Change

GAITHERSBURG, Md., Sept. 18, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”) announced today that it has changed the venue of its 2020 Annual Meeting of Stockholders...
September 16, 2020 07:30 ET | Source: OpGen, Inc.

Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing

Published Study on Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance Presented Study on Long-Read Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing...
September 08, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test

Ares Genetics nominated for the 40th Austrian Innovation Award by Federal Ministry for Digital and Economic Affairs ARESupa – Universal Pathogenome Assay nominated by expert jury for Austria’s most...